Literature DB >> 20428716

[Reliability and validity of the geriatric depression scale in elderly individuals with coronary artery disease].

Míriam Ximenes Pinho1, Osvladir Custódio, Marcia Makdisse, Antonio Carlos C Carvalho.   

Abstract

BACKGROUND: The prevalence of depression in individuals with coronary artery disease (CAD) is high. The Geriatric Depression Scale (GDS) is a broadly used tool to screen for depression in elderly individuals. In Brazil, the psychometric properties of the short version have not been adequately assessed.
OBJECTIVE: To evaluate the psychometric properties of the short version of the GDS in patients with CAD treated at a Cardiology Outpatient Clinic.
METHODS: The present is a cross-sectional study that assessed 209 elderly individuals (> or = 65 years) with CAD using the GDS-15, the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), the Brazilian OARS Multidimensional Function Assessment Questionnaire (BOMFAQ) and The Cambridge Examination for Mental Disorders of the Elderly (CAMDEX). The internal consistency of the GDS-15 was calculated through the KR-20. A factorial analysis of this scale was carried out. The GDS-15 scores were compared with the diagnoses of depression (DSM-IV) for the validity of criteria. At the analysis of concurrent validity, the same scores were correlated with those of the CAMDEX, mini-mental state examination (MMSE), Cambridge Cognitive Examination (CAMCOG) and BOMFAQ depression scales.
RESULTS: Clinical depression was diagnosed in 35.71% of the sample assessed according to the DSM-IV. For the diagnosis of major depression or dystimia, the cutoff 5/6 presented moderate accuracy (AUROC = 0.84), sensitivity of 79.92% and specificity of 78.29%. The internal consistency was 0.80. At the factorial analysis, three obtained factors explained 52.72% of the total variance that was observed. The GDS-15 scores correlated with those of the CAMDEX depression scale.
CONCLUSION: In general, the GDS-15 presented good reliability and validity (concurrent and of criterion). In cardiologic settings, its use, which is simple and fast, can be utilized in the screening for depression.

Entities:  

Mesh:

Year:  2010        PMID: 20428716     DOI: 10.1590/s0066-782x2010005000032

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  3 in total

Review 1.  Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review.

Authors:  Brett D Thombs; Michelle Roseman; James C Coyne; Peter de Jonge; Vanessa C Delisle; Erin Arthurs; Brooke Levis; Roy C Ziegelstein
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

2.  Indicators of depression in elderly and different screening methods.

Authors:  Amanda Gilvani Cordeiro Matias; Marília de Andrade Fonsêca; Maria de Lourdes de Freitas Gomes; Marcos Antonio Almeida Matos
Journal:  Einstein (Sao Paulo)       Date:  2016 Jan-Mar

3.  Association between fibroblast growth factor 23 and functional capacity among independent elderly individuals.

Authors:  Lara Miguel Quirino Araújo; Patrícia Ferreira do Prado Moreira; Clineu de Mello Almada Filho; Luciano Vieira de Araújo; Aline Granja Costa; Ricardo de Castro Cintra Sesso; John P Bilezikian; Marise Lazaretti-Castro; Maysa Seabra Cendoroglo
Journal:  Einstein (Sao Paulo)       Date:  2021-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.